FDA Approved: ZOMACTON — Supplemental Application (Ferring Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for ZOMACTON (somatropin) from Ferring Pharmaceuticals, likely to update labeling or expand indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Growth Hormone Deficiency
• Idiopathic Short Stature
• Prader-willi Syndrome
• Small For Gestational Age
• Turner Syndrome

Drugs mentioned

• ZOMACTON (Somatropin)

Snippet

SUPPL AP for ZOMACTON (SOMATROPIN)